MarinHKollefMD

Pulmonology • Saint Louis, MO

Critical Care Medicine, Pleural Disease

Professor, Internal Medicine, Washington University School of Medicine

Join to view full profile

Are you Dr. Kollef?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 71 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
1 Barnes Jewish Hospital Plz
Saint Louis, MO 63110
Phone+1 314-454-8764

Fax+1 314-454-5571

Summary

Dr. Marin Kollef, MD is a pulmonologist in Saint Louis, Missouri. He is currently licensed to practice medicine in Missouri. He is affiliated with Barnes-Jewish Hospital and is a Professor at Washington University School of Medicine.

Education & Training

Madigan Army Medical CenterFellowship, Pulmonary Disease, 1986 - 1988
Madigan Army Medical CenterResidency, Internal Medicine, 1983 - 1986
University of Rochester School of Medicine and DentistryClass of 1983

Certifications & Licensure

MO State Medical License 1992 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 2000

Clinical Trials

Trial of Iseganan in Prevention of Ventilator-Associated Pneumonia Start of enrollment: 2003 Sep 01
Terminated
Phase 2, Phase 3
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP) Start of enrollment: 2002 Nov 01
Completed
Phase 3
Hemodynamic Optimization By Non-Invasive Determination Of Cardiac Output In Critically Ill Patients Start of enrollment: 2010 Jan 01
Completed
Not Applicable
Respiratory Disease Management Start of enrollment: 2012 Jul 01
Completed
Not Applicable
Clinical Trials to Reduce the Risk of Antimicrobial Resistance Start of enrollment: 2010 Sep 01
Terminated
Phase 2
Early Warning System Start of enrollment: 2013 Feb 01
Completed
Not Applicable
Common Canister Protocol for Inhaler Administration in Mechanically Ventilated Patients Start of enrollment: 2013 Jun 01
Completed
Phase 4
Pneumonia in the Intensive Care Unit (ICU) Setting Start of enrollment: 2016 Jan 01
Completed
High-Flow Oxygen Therapy Following Tracheostomy Start of enrollment: 2018 May 17
Completed
Not Applicable
Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis Start of enrollment: 2021 Jun 29
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Length of hospital and intensive care unit stay in patients with invasive candidiasis and/or candidemia treated with rezafungin: a pooled analysis of two randomised co...
Patrick M Honoré, Matteo Bassetti, Oliver A Cornely, Herve Dupont, Jesús Fortún
Critical Care. 2024-11-11
Performance of Risk Models for Antimicrobial Resistance in Adult Patients With Sepsis.
M Cristina Vazquez Guillamet, Hanyang Liu, Andrew Atkinson, Victoria J Fraser, Chenyang Lu
JAMA Network Open. 2024-11-04
Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised tr...
Patrick M Honoré, Massimo Girardis, Marin Kollef, Oliver A Cornely, George R Thompson 3rd
Critical Care. 2024-10-28

Press Mentions

Multidrug-Resistant Gram-Negative Infections Treatable with Newer Antibiotics, but Guidance Is NeededDecember 9th, 2022
Ceftolozane/Tazobactam Efficacious for Ventilated Nosocomial PneumoniaApril 16th, 2019
Results of Phase 3 Trial Evaluating Merck’s ZERBAXAApril 13th, 2019
Join now to see all